Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PLH-2301 in Elderly Patients With Sarcopenia
NCT07390552Phase 2Recruiting
- Sponsor
- Pluto Immunotherapeutics
- Start
- May 2026
- Primary completion
- Jun 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of PLH-2301 in Sarcopenia, sponsored by Pluto Immunotherapeutics. Started May 2026; status: recruiting.
02
Drugs
PLH-2301
03
Conditions
Sarcopenia
Beyond the preview
Go deeper on NCT07390552.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07390552.